NovFS-IP
/ NovMetaPharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 30, 2024
Orphan Designation: treatment of idiopathic pulmonary fibrosis
(FDA)
- Date Designated: 05/30/2024
Orphan drug • Idiopathic Pulmonary Fibrosis
1 to 1
Of
1
Go to page
1